Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04460456
Title A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Silverback Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Duke University Durham North Carolina 27708 United States Details
University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
The START Center for Cancer Care San Antonio Texas 78229 United States Details
Macquarie University Hospital Clinical Trials Unit Sydney New South Wales 2109 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Breast Cancer Research Centre - WA Nedlands Western Australia 6009 Australia Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field